Literature DB >> 26108893

Osteoclast TGF-β Receptor Signaling Induces Wnt1 Secretion and Couples Bone Resorption to Bone Formation.

Megan M Weivoda1, Ming Ruan1, Larry Pederson1, Christine Hachfeld1, Rachel A Davey2, Jeffrey D Zajac2, Jennifer J Westendorf3, Sundeep Khosla1, Merry Jo Oursler1.   

Abstract

Osteoblast-mediated bone formation is coupled to osteoclast-mediated bone resorption. These processes become uncoupled with age, leading to increased risk for debilitating <span class="Disease">fractures. Therefore, understanding how osteoblasts are recruited to sites of resorption is vital to treating age-related <span class="Disease">bone loss. Osteoclasts release and activate TGF-β from the bone matrix. Here we show that osteoclast-specific inhibition of TGF-β receptor signaling in mice results in osteopenia due to reduced osteoblast numbers with no significant impact on osteoclast numbers or activity. TGF-β induced osteoclast expression of Wnt1, a protein crucial to normal bone formation, and this response was blocked by impaired TGF-β receptor signaling. Osteoclasts in aged murine bones had lower TGF-β signaling and Wnt1 expression in vivo. Ex vivo stimulation of osteoclasts derived from young or old mouse bone marrow macrophages showed no difference in TGF-β-induced Wnt1 expression. However, young osteoclasts expressed reduced Wnt1 when cultured on aged mouse bone chips compared to young mouse bone chips, consistent with decreased skeletal TGF-β availability with age. Therefore, osteoclast responses to TGF-β are essential for coupling bone resorption to bone formation, and modulating this pathway may provide opportunities to treat age-related bone loss.
© 2015 American Society for Bone and Mineral Research.

Entities:  

Keywords:  BONE REMODELING; COUPLING; OSTEOCLAST; TGF-β; WNT1

Mesh:

Substances:

Year:  2015        PMID: 26108893      PMCID: PMC4758668          DOI: 10.1002/jbmr.2586

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  50 in total

1.  TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival.

Authors:  Anne Gingery; Elizabeth W Bradley; Larry Pederson; Ming Ruan; Nikki J Horwood; Merry Jo Oursler
Journal:  Exp Cell Res       Date:  2008-06-13       Impact factor: 3.905

2.  Suggested sequential mode of control of changes in cell behaviour in adult bone remodelling.

Authors:  R Hattner; B N Epker; H M Frost
Journal:  Nature       Date:  1965-05-01       Impact factor: 49.962

3.  Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones.

Authors:  J Pfeilschifter; G R Mundy
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

4.  Osteoclast synthesis and secretion and activation of latent transforming growth factor beta.

Authors:  M J Oursler
Journal:  J Bone Miner Res       Date:  1994-04       Impact factor: 6.741

5.  Age-related decreases in insulin-like growth factor-I and transforming growth factor-beta in femoral cortical bone from both men and women: implications for bone loss with aging.

Authors:  V Nicolas; A Prewett; P Bettica; S Mohan; R D Finkelman; D J Baylink; J R Farley
Journal:  J Clin Endocrinol Metab       Date:  1994-05       Impact factor: 5.958

6.  Transforming growth factor beta 1 induces CXCL16 and leukemia inhibitory factor expression in osteoclasts to modulate migration of osteoblast progenitors.

Authors:  Kuniaki Ota; Patrick Quint; Megan M Weivoda; Ming Ruan; Larry Pederson; Jennifer J Westendorf; Sundeep Khosla; Merry Jo Oursler
Journal:  Bone       Date:  2013-07-25       Impact factor: 4.398

7.  Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations.

Authors:  Matteo M Guerrini; Cristina Sobacchi; Barbara Cassani; Mario Abinun; Sara S Kilic; Alessandra Pangrazio; Daniele Moratto; Evelina Mazzolari; Jill Clayton-Smith; Paul Orchard; Fraser P Coxon; Miep H Helfrich; Julie C Crockett; David Mellis; Ashok Vellodi; Ilhan Tezcan; Luigi D Notarangelo; Michael J Rogers; Paolo Vezzoni; Anna Villa; Annalisa Frattini
Journal:  Am J Hum Genet       Date:  2008-07       Impact factor: 11.025

8.  Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss.

Authors:  P D Delmas; D Stenner; H W Wahner; K G Mann; B L Riggs
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

9.  Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans.

Authors:  Matthew M Roforth; Koji Fujita; Ulrike I McGregor; Salman Kirmani; Louise K McCready; James M Peterson; Matthew T Drake; David G Monroe; Sundeep Khosla
Journal:  Bone       Date:  2013-10-29       Impact factor: 4.398

10.  Osteoclasts control osteoblast chemotaxis via PDGF-BB/PDGF receptor beta signaling.

Authors:  Maria Arantzazu Sanchez-Fernandez; Anne Gallois; Thilo Riedl; Pierre Jurdic; Bernard Hoflack
Journal:  PLoS One       Date:  2008-10-27       Impact factor: 3.240

View more
  24 in total

1.  RIP140 in monocytes/macrophages regulates osteoclast differentiation and bone homeostasis.

Authors:  Bomi Lee; Urszula T Iwaniec; Russell T Turner; Yi-Wei Lin; Bart L Clarke; Anne Gingery; Li-Na Wei
Journal:  JCI Insight       Date:  2017-04-06

Review 2.  Emerging insights into the comparative effectiveness of anabolic therapies for osteoporosis.

Authors:  Eben G Estell; Clifford J Rosen
Journal:  Nat Rev Endocrinol       Date:  2020-11-04       Impact factor: 43.330

Review 3.  Osteoclast differentiation by RANKL and OPG signaling pathways.

Authors:  Nobuyuki Udagawa; Masanori Koide; Midori Nakamura; Yuko Nakamichi; Teruhito Yamashita; Shunsuke Uehara; Yasuhiro Kobayashi; Yuriko Furuya; Hisataka Yasuda; Chie Fukuda; Eisuke Tsuda
Journal:  J Bone Miner Metab       Date:  2020-10-20       Impact factor: 2.626

Review 4.  Novel insights into the coupling of osteoclasts and resorption to bone formation.

Authors:  Margaret M Durdan; Ruth D Azaria; Megan M Weivoda
Journal:  Semin Cell Dev Biol       Date:  2021-10-30       Impact factor: 7.727

Review 5.  Bone remodeling: an operational process ensuring survival and bone mechanical competence.

Authors:  Simona Bolamperti; Isabella Villa; Alessandro Rubinacci
Journal:  Bone Res       Date:  2022-07-18       Impact factor: 13.362

6.  Histone deacetylase 3 supports endochondral bone formation by controlling cytokine signaling and matrix remodeling.

Authors:  Lomeli R Carpio; Elizabeth W Bradley; Meghan E McGee-Lawrence; Megan M Weivoda; Daniel D Poston; Amel Dudakovic; Ming Xu; Tamar Tchkonia; James L Kirkland; Andre J van Wijnen; Merry Jo Oursler; Jennifer J Westendorf
Journal:  Sci Signal       Date:  2016-08-09       Impact factor: 8.192

Review 7.  Bone metastasis: the importance of the neighbourhood.

Authors:  Peter I Croucher; Michelle M McDonald; T John Martin
Journal:  Nat Rev Cancer       Date:  2016-05-25       Impact factor: 60.716

8.  TGFβ Regulation of Perilacunar/Canalicular Remodeling Is Sexually Dimorphic.

Authors:  Neha S Dole; Cristal S Yee; Courtney M Mazur; Claire Acevedo; Tamara Alliston
Journal:  J Bone Miner Res       Date:  2020-05-13       Impact factor: 6.390

9.  Smad4 is required to inhibit osteoclastogenesis and maintain bone mass.

Authors:  Mayu Morita; Shigeyuki Yoshida; Ryotaro Iwasaki; Tetsuro Yasui; Yuiko Sato; Tami Kobayashi; Ryuichi Watanabe; Takatsugu Oike; Kana Miyamoto; Masamichi Takami; Keiko Ozato; Chu-Xia Deng; Hiroyuki Aburatani; Sakae Tanaka; Akihiko Yoshimura; Yoshiaki Toyama; Morio Matsumoto; Masaya Nakamura; Hiromasa Kawana; Taneaki Nakagawa; Takeshi Miyamoto
Journal:  Sci Rep       Date:  2016-10-12       Impact factor: 4.379

10.  The Effect of Long-Term Exercise on the Production of Osteoclastogenic and Antiosteoclastogenic Cytokines by Peripheral Blood Mononuclear Cells and on Serum Markers of Bone Metabolism.

Authors:  J Kelly Smith; Rhesa Dykes; David S Chi
Journal:  J Osteoporos       Date:  2016-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.